Webinar Day Two

12:50 pm - 1:00 pm Chairperson's Opening Address

1:00 pm - 1:40 pm Connecting Pharma with the Pharmacist: Roche’s Platform for Integration and Information

Dr. Philipp Schlatter - Community of Practice Leader, Post Trial Access & Drug Supply, Roche


img

Dr. Philipp Schlatter

Community of Practice Leader, Post Trial Access & Drug Supply
Roche

1:40 pm - 2:20 pm Session Reserved for Clinigen

2:20 pm - 3:00 pm Panel Discussion: Building a Proactive Development Strategy to Avoid Reactive Decisions Across Your Route to Market

Nisha Shaunak - Lead Pharmacist for Oncology, Guy’s and St Thomas’ & Specialised Cancer Commissioning Pharmacist, NHS England
img

Nisha Shaunak

Lead Pharmacist for Oncology, Guy’s and St Thomas’ & Specialised Cancer Commissioning Pharmacist
NHS England

2:20 pm - 3:00 pm Session To Be Announced

3:40 pm - 4:40 pm Co-Creating Expanded Access Resources: Transforming information for transparency

Christine MacCracken - Director, Patient Strategies & Solutions, Office of the Chief Medical Officer, Janssen


In this session, you will have the opportunity to:

  • Discuss experiences in identifying potential treatment options
  • Review and provide input into new EA patient resource
  • Join a global dialogue about EA

img

Christine MacCracken

Director, Patient Strategies & Solutions, Office of the Chief Medical Officer
Janssen

4:40 pm - 5:20 pm Session To Be Announced

A discussion from multiple stakeholder perspectives on what’s currently happening in various therapeutic areas with all the attention current being focused on COVID-19. Focus topics will include the conduct of trials, investment into new research, patient engagement and regulatory pathways.

The central question to be asked will be: How do we justify what we are doing under – and with - Covid in comparison to what we are doing for other diseases?

img

Alison Bateman-House

Co-Chair
NYU Working Group on Compassionate Use and Preapproval Access (CUPA)

img

Pat Furlong

Founding President & CEO
Parent Project Muscular Dystrophy (PPMD) and CUPA Member

img

Kenneth Moch

President & CEO
Cognition Therapeutics and CUPA Member

6:00 pm - 6:10 pm Chairperson's Closing Address